Blue Bell, PA — August 28, 2025 — inSeption Group, a leading full-service global outsourcing company specializing in drug development solutions, is pleased to announce the integration of PreciseDox, a respected medical writing vendor known for its scientific rigor, regulatory expertise, and client-focused delivery model.
This strategic move strengthens inSeption Group’s commitment to providing comprehensive, end-to-end services across the clinical development spectrum. By merging with the PreciseDox team, inSeption significantly enhances its regulatory and scientific communications capabilities, further elevating its ability to support inSeption’s and PreciseDox’s clients through critical medical writing milestones.
“The integration with PreciseDox represents a key milestone in our growth strategy,” said Brian Sulpizio, Managing Partner of inSeption Group. “Their reputation for quality, agility, and precision perfectly aligns with our mission to elevate outsourcing partnerships and deliver exceptional outcomes.”
Founded in 1997, PreciseDox has supported a broad range of pharmaceutical and biotechnology clients with high-quality clinical and regulatory documentation, including INDs, NDAs, BLAs, briefing documents, and pivotal Phase 2 clinical study reports. The company’s broad subject matter expertise and client-centric approach have made it a trusted partner in the industry.
With the addition of the PreciseDox team, inSeption expands its medical writing function and strengthens its ability to scale support for global regulatory submissions, scientific publications, and clinical trial communications—ensuring seamless collaboration with its broader biometrics, clinical operations, and quality services.
“Joining inSeption allows us to offer our clients expanded resources without compromising the personalized service that defines us,” said Nancy Sobieck, President of PreciseDox. “We are excited to bring our expertise to a larger platform and contribute to inSeption’s mission of setting a new standard in outsourcing.”
The transition is already underway, with no disruption expected to existing client engagements. Clients can expect the same high level of service, now backed by inSeption’s expanded infrastructure and multidisciplinary expertise.
About inSeption Group
inSeption Group is a full-service outsourcing partner delivering comprehensive drug development services to pharmaceutical and biotechnology companies worldwide. With a focus on expertise, integrity, and transparency, inSeption builds cohesive teams of seasoned professionals dedicated to accelerating clinical development and regulatory success.
About PreciseDox
PreciseDox is a medical writing services provider specializing in regulatory, clinical, and quality control. Known for its deep industry knowledge, quality-driven processes, and personalized attention, PreciseDox has supported pharmaceutical and biotech clients for the past 28 years through complex development programs and regulatory submissions.
For media inquiries, contact:
Kristin Morris
Senior Director, Corporate Communications
267-397-8980
kmorris@inseptiongroup.com